Abstract 2189
Background
We recently reported the usefulness of apolipoprotein A2 isoforms (apoA2-i) as a plasma/serum biomarker for the early detection of pancreatic cancer (PC) and its risk diseases, and the level of ApoA2-ATQ/AT, which is one of apoA2-i, was significantly decreased in early stage PC and risk diseases. To evaluate the possibility of usefulness as the screening biomarker, we prospectively tested the performance of ApoA2-ATQ/AT as a first screening method for PC and its risk diseases in general population.
Methods
Study participants were prospectively enrolled from the subjects of medical checkup at 6 institutions between Oct 2015 and Jan 2017. We measured the plasma level of ApoA2-ATQ/AT by using ELISA, and all participants with the positive results from the level of ApoA2-ATQ/AT (ApoA2-ATQ/AT < 35 μg/mL) were recommended for 2nd examination with contrast enhanced-CT (CECT), MRI, or EUS.
Results
Among a total of 5,120 participants registered in this study, 83 were positive (Positive rate: 1.6%). In the 83 subjects with the positive results, 55 (66.3%) underwent 2nd examination. Finally, pancreatic diseases were detected in 23 (41.8%) of 55. They included 1 PC, 12 pancreatic cystic lesions (PCL), and 3 chronic pancreatitis (CP). Furthermore, 14.5% of ApoA2-ATQ/AT positive subjects had abnormal ultrasonographic findings in the pancreas, while the subjects with ultrasonographic abnormalities of the pancreas under a medical checkup were 3.2% of the participants who underwent transabdominal ultrasonography. Taken together, ApoA2-ATQ/AT could significantly accumulate the subjects with abnormal ultrasonographic findings by 4.53 times in comparison with a normal medical checkup for general population.
Conclusions
Plasma ApoA2-ATQ/AT as a first screening method in general population could improve an efficiency of detection of PC and its high-risk diseases.
Clinical trial identification
Legal entity responsible for the study
Kobe University Graduate School of Medicine, Department of Gastroenterology.
Funding
Japan Agency for Medical Research and Development.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract